Knowledge and News for the Global Fight Against Cancer.
The biopharmaceutical landscape is currently characterized by a complex interplay of strategic restructurings, significant workforce...
Colorectal cancer (CRC), once primarily associated with older age, is experiencing an alarming surge among...
The U.S. Food and Drug Administration (FDA) has granted an expanded approval for GSK’s respiratory...
The U.S. Food and Drug Administration (FDA) has granted Investigational New Drug (IND) clearance for...
The annual IO360° Summit, held in February in Boston, Massachusetts, served as a crucial nexus...
A kidney cancer diagnosis, historically a harbinger of profound uncertainty and fear, is increasingly met...
Ugur Sahin and Özlem Türeci, the visionary co-founders who meticulously steered BioNTech from a nascent...
For over 70 years, the Cancer Research Institute (CRI) has stood at the vanguard of...
The biopharmaceutical industry is currently a hotbed of activity, marked by significant regulatory milestones, innovative...
Basel, Switzerland – Hopes for Roche’s amylin-targeting obesity drug, petrelintide, have been tempered following the...
admin